COMPARISON OF TRANSDERMAL AND SUBCUTANEOUS TERIPARATIDE EFFECTS ON MARKERS OF BONE TURNOVER AND SAFETY IN POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Kenan, Y. [1 ]
Kochba, E. [1 ]
Shahar, M. [1 ]
Gadasi, H. [1 ]
Levin, G. [1 ]
Foldes, A. J. [2 ]
Ish-Shalom, S. [3 ]
Matsumoto, T. [4 ]
Lindsay, R. [5 ]
Christiansen, C. [7 ]
Neer, R. [6 ]
机构：
[1] TransPharma Med Ltd, Lod, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Rambam Hlth Care Ctr, Metabol Bone Dis Unit, Haifa, Israel
[4] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan
[5] Helen Hayes Hosp, W Haverstraw, NY USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Nord Biosci, Herlev, Denmark
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [31] Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis
    Eastell, Richard
    Reid, David M.
    Vukicevic, Slobodan
    Ensrud, Kristine E.
    LaCroix, Andrea Z.
    Thompson, John R.
    Thompson, David D.
    Cummings, Steven R.
    BONE, 2012, 50 (05) : 1135 - 1140
  • [32] Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
    Paul E Goss
    Peyman Hadji
    Milayna Subar
    Paula Abreu
    Torben Thomsen
    Jose Banke-Bochita
    Breast Cancer Research, 9
  • [33] Effects of Bazedoxifene on Bone Mineral Density, Bone Turnover, and Safety in Postmenopausal Japanese Women With Osteoporosis
    Itabashi, Akira
    Yoh, Kousei
    Chines, Arkadi A.
    Miki, Takami
    Takada, Masahiko
    Sato, Hiroshi
    Gorai, Itsuo
    Sugimoto, Toshitsugu
    Mizunuma, Hideki
    Ochi, Hiroshi
    Constantine, Ginger D.
    Ohta, Hiroaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 519 - 529
  • [34] Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
    Goss, Paul E.
    Hadji, Peyman
    Subar, Milayna
    Abreu, Paula
    Thomsen, Torben
    Banke-Bochita, Jose
    BREAST CANCER RESEARCH, 2007, 9 (04)
  • [35] BIOCHEMICAL MARKERS OF BONE TURNOVER IN TREATMENT WITH TERIPARATIDE AND TERIPARATIDE IN COMBINATION WITH DENOSUMAB
    Blazquez, J. A.
    Navarro-Martinez, A.
    Torres, J.
    Navarro-Casado, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S311 - S311
  • [36] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    Sugimoto, T.
    Nakamura, T.
    Nakamura, Y.
    Isogai, Y.
    Shiraki, M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1173 - 1180
  • [37] Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    T. Sugimoto
    T. Nakamura
    Y. Nakamura
    Y. Isogai
    M. Shiraki
    Osteoporosis International, 2014, 25 : 1173 - 1180
  • [38] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [39] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    Advances in Therapy, 2006, 23 : 842 - 853
  • [40] Relationship of bone mineral density and biochemical markers of bone turnover in postmenopausal women
    Vuceljic, M
    Vucetic, D
    Mihajlovic, R
    Ilic-Stojanovic, O
    Nikolajevic, R
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S136 - S137
12345